| Miltefosine, a promising novel agent for schistosomiasis mansoni MM Eissa, MZ El-Azzouni, EI Amer, NM Baddour International journal for parasitology 41 (2), 235-242, 2011 | 85 | 2011 |
| Miltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical study MM Eissa, RM El-Moslemany, AA Ramadan, EI Amer, MZ El-Azzouni, ... PloS one 10 (11), e0141788, 2015 | 79 | 2015 |
| Giardia lamblia: a new target for miltefosine MM Eissa, EI Amer International journal for parasitology 42 (5), 443-452, 2012 | 48 | 2012 |
| Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia EI Amer, SF Mossallam, H Mahrous Experimental parasitology 146, 52-63, 2014 | 46 | 2014 |
| Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles SF Mossallam, EI Amer, RG Diab Experimental parasitology 144, 14-21, 2014 | 44 | 2014 |
| Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni SF Mossallam, EI Amer, MH El-Faham Acta tropica 143, 36-46, 2015 | 41 | 2015 |
| Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis MM Eissa, EI Amer, SMF El Sawy Experimental parasitology 128 (4), 382-390, 2011 | 41 | 2011 |
| Could miltefosine be used as a therapy for toxoplasmosis? MM Eissa, AMA Barakat, EI Amer, LK Younis Experimental parasitology 157, 12-22, 2015 | 37 | 2015 |
| Biological and proteomic studies of Schistosoma mansoni with decreased sensitivity to praziquantel IF Abou-El-Naga, EI Amer, LM Boulos, MH El-Faham, NM Abou Seada, ... Comparative Immunology, Microbiology and Infectious Diseases 66, 101341, 2019 | 24 | 2019 |
| Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model SF Mossallam, EI Amer, RE Ewaisha, AM Khalil, HM Aboushleib, ... BMC infectious diseases 15, 1-16, 2015 | 24 | 2015 |
| Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection RE Ewaisha, M Bahey-El-Din, SF Mossallam, EI Amer, HM Aboushleib, ... Experimental parasitology 145, 51-60, 2014 | 21 | 2014 |
| Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis EI Amer, MM Eissa, SF Mossallam Journal of Parasitic Diseases 40, 475-484, 2016 | 20 | 2016 |
| Impact of the age of Biomphalaria alexandrina snails on Schistosoma mansoni transmission: modulation of the genetic outcome and the internal defence system of the snail IF Abou-El-Naga, HAEM Sadaka, EI Amer, IH Diab, SIAEH Khedr Memórias do Instituto Oswaldo Cruz 110, 585-595, 2015 | 19 | 2015 |
| Synthesis and biological evaluation of a novel class as antileishmanial agent MNS Saudi, MMA El-Semary, RY Elbayaa, MI Jaeda, MM Eissa, EI Amer, ... Medicinal Chemistry Research 21, 257-267, 2012 | 17 | 2012 |
| Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens MH El-Faham, MM Eissa, JE Igetei, EI Amer, S Liddell, MZ El-Azzouni, ... PLoS neglected tropical diseases 11 (8), e0005853, 2017 | 15 | 2017 |
| Repositioning of chlorambucil as a potential anti-schistosomal agent MM Eissa, SF Mossallam, EI Amer, LK Younis, HA Rashed Acta Tropica 166, 58-66, 2017 | 11 | 2017 |
| Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel EI Amer, IF Abou-El-Naga, LM Boulos, HS Ramadan, SS Younis Biomédica 42 (1), 67-84, 2022 | 8 | 2022 |
| Miltefosine for Old World cutaneous leishmaniasis: An experimental study on Leishmania major infected mice MM Eissa, EI Amer, SF Mossallam, MM Gomaa, NM Baddour Alexandria Journal of Medicine 48 (3), 261–271-261–271, 2012 | 7 | 2012 |
| Biological and biochemical studies for characterization of some Egyptian Trichomonas vaginalis isolates LM Boulos, MM El Temsahy, SM Aly, ESI El Agamy, EI Amer PUJ-Parasitologists United Journal 5 (2), 175-188, 2012 | 6 | 2012 |
| Nano-encapsulated antioxidant: retinoic acid as a natural mucosal adjuvant for intranasal immunization against chronic experimental toxoplasmosis DE Said, EI Amer, E Sheta, S Makled, FM Arafa, HE Diab Tropical Medicine and Infectious Disease 8 (2), 106, 2023 | 4 | 2023 |
